Ali, I U <br/><br/>
Angiogenesis as a potential biomarker in prostate cancer chemoprevention trials.  [electronic resource] 

 -  Urology  Apr 2001 
 - 143-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1527-9995 
<br/><br/><label>Standard No.: </label>10.1016/s0090-4295(00)00961-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Biomarkers--analysis<br/>Disease Progression<br/>Endothelial Growth Factors--metabolism<br/>Gene Silencing<br/>Genes, Tumor Suppressor<br/>Humans<br/>Lymphokines--metabolism<br/>Male<br/>Melanoma--metabolism<br/>Mice<br/>Neovascularization, Pathologic--diagnosis<br/>Phenotype<br/>Polymerase Chain Reaction--methods<br/>Prostatic Intraepithelial Neoplasia--blood supply<br/>Prostatic Neoplasms--blood supply<br/>Transplantation, Heterologous<br/>Vascular Endothelial Growth Factor A<br/>Vascular Endothelial Growth Factors